Depression Clinical Trial
Official title:
Pilot Study of Mind-Body Skills Groups for Adolescents With Depression in Primary Care
Verified date | March 2020 |
Source | Indiana University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The Center for Mind -Body Medicine has developed a mind-body skills group program that incorporates meditation, guided imagery, breathing techniques, autogenic training, biofeedback, genograms, and self-expression through words, drawings, and movement. These mind-body skills are designed to increase self-awareness and self-regulation. This program has been shown to significantly improve depression symptoms in children and adolescents with posttraumatic stress disorder in Gaza, but it has not yet been tested in a US adolescent population. The purpose of this study is to determine the feasibility of using mind-body skills groups to reduce depression in adolescents and to investigate the effects of the program on factors such as self-efficacy, mindfulness and rumination which are likely to mediate improvement.
Status | Completed |
Enrollment | 49 |
Est. completion date | September 4, 2019 |
Est. primary completion date | September 4, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 13 Years to 17 Years |
Eligibility |
Inclusion Criteria: - Eskenazi Primary Care patients at time of screening - 13-17 years old - Diagnosis of depression confirmed by Mini International Neuropsychiatric Interview (MINI) Kid Screen (with adolescent) - English speaking - Willingness to attend mind body skills group for duration of the intervention (10 sessions over approximately 10 weeks) Exclusion Criteria: - History of bipolar disorder or psychosis - Acute and immediate risk of suicide, determined by clinical assessment - Lack of capacity to assent (adolescent) or lack of capacity to consent (parent/guardian) - Previous participation by the adolescent in the Eskenazi Mind Body Group intervention |
Country | Name | City | State |
---|---|---|---|
United States | Eskenazi Health Primary Care | Indianapolis | Indiana |
Lead Sponsor | Collaborator |
---|---|
Indiana University | Eskenazi Health, The Center for Mind-Body Medicine |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Children's Depression Inventory-2 (CDI-2) scores | self report long version (28 items) to assess the presence and severity of depressive symptoms in children | from baseline to within one month after end of intervention | |
Primary | Change in Children's Depression Inventory-2 (CDI-2) scores | self report long version (28 items) to assess the presence and severity of depressive symptoms in children | from baseline to approximately 3 months after end of intervention | |
Secondary | Change in Patient Health Questionnaire-9 (PHQ-9) score | self report (9 questions) to screen for the presence and severity of depression | from baseline to within one month after end of intervention | |
Secondary | Change in Patient Health Questionnaire-9 (PHQ-9) score | self report (9 questions) to screen for the presence and severity of depression | from baseline to approximately 3 months after end of intervention | |
Secondary | Change in Rumination Subscale of the Children's Response Style Questionnaire Score | self report (13 questions) of rumination symptoms | from baseline to within one month after end of intervention | |
Secondary | Change in Rumination Subscale of the Children's Response Style Questionnaire Score | self report (13 questions) of rumination symptoms | from baseline to approximately 3 months after end of intervention | |
Secondary | Change in Mindful Attention Awareness Scale-Adolescent (MAAS) score | self report (14 questions) designed to assess open or receptive awareness of and attention to what is taking place in the present | from baseline to within one month after end of intervention | |
Secondary | Change in Mindful Attention Awareness Scale-Adolescent (MAAS) score | self report (14 questions) designed to assess open or receptive awareness of and attention to what is taking place in the present | from baseline to approximately 3 months after end of intervention | |
Secondary | Change in Self-Efficacy Questionnaire for Depression in Adolescents (SEQ-DA) score | self report (12 items) designed to measure self-perceived ability to cope with depressive symptoms | from baseline to within one month after end of intervention | |
Secondary | Change in Self-Efficacy Questionnaire for Depression in Adolescents (SEQ-DA) score | self report (12 items) designed to measure self-perceived ability to cope with depressive symptoms | from baseline to approximately 3 months after end of intervention | |
Secondary | Change in Suicide Ideation Questionnaire (SIQ) score | self report (30 or 15 items depending on grade level) to assess frequency of suicidal ideation | from baseline to within one month after end of intervention | |
Secondary | Change in Suicide Ideation Questionnaire (SIQ) score | self report (30 or 15 items depending on grade level) to assess frequency of suicidal ideation | from baseline to approximately 3 months after end of intervention | |
Secondary | Acceptability Questionnaire | self report (15 items) intervention acceptability assessment of usefulness and helpfulness of the intervention | within one month after end of intervention | |
Secondary | Acceptability Questionnaire | self report (15 items) intervention acceptability assessment of usefulness and helpfulness of the intervention | approximately 3 months after end of intervention | |
Secondary | Acceptability Questionnaire - open-ended questions for qualitative analyses | 3 open-ended questions to gather qualitative data about the usefulness and helpfulness of the intervention | within one month after end of intervention | |
Secondary | Acceptability Questionnaire - open-ended questions for qualitative analyses | 3 open-ended questions to gather qualitative data about the usefulness and helpfulness of the intervention | approximately 3 months after end of intervention | |
Secondary | Change in Hope Scale Score | self report (12 items), 4-point Likert scale(1=Definitely False to 4=Definitely True) evaluates global hope (range 8-32); there are also 2 subscales: hope agency (range 4-16) and hope pathways (range 4-16) includes distracter items global hope score calculated by summing the hope agency and hope pathways scores (omitting distracter items) higher scores indicate a person has higher hope |
from baseline to within one month after end of intervention | |
Secondary | Change in Hope Scale Score | self report (12 items), 4-point Likert scale(1=Definitely False to 4=Definitely True) evaluates global hope (range 8-32); there are also 2 subscales: hope agency (range 4-16) and hope pathways (range 4-16) includes distracter items global hope score calculated by summing the hope agency and hope pathways scores (omitting distracter items) higher scores indicate a person has higher hope |
from baseline to approximately 3 months after end of intervention | |
Secondary | Change in Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) Score | self report (14 items) to measure positive affect, satisfying interpersonal relationships, and positive functioning 5-point Likert scale (1=none of the time to 5=all of the time) total score is calculated by summing each item score (range 14-70) higher scores represent increased levels of mental wellbeing |
from baseline to within one month after end of intervention | |
Secondary | Change in Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) Score | self report (14 items) to measure positive affect, satisfying interpersonal relationships, and positive functioning (range 14-70) 5-point Likert scale (1=none of the time to 5=all of the time) total score is calculated by summing each item score (range 14-70) higher scores represent increased levels of mental wellbeing |
from baseline to approximately 3 months after end of intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |